Recently, we identified the two myeloid related protein-8 (MRP8) (S100A8) and MRP14 (S100A9) as fatty acid-binding proteins (Klempt, M., Melkonyan, H., Nacken, W., Wiesmann, D., Holtkemper, U., and Sorg, C. (1997) FEBS Lett. 408, 81-84). Here we present data that the S100A8/A9 protein complex represents the exclusive arachidonic acid-binding proteins in human neutrophils. Binding and competition studies revealed evidence that (i) fatty acid binding was dependent on the calcium concentration; (ii) fatty acid binding was specific for the protein complex formed by S100A8 and S100A9, whereas the individual components were unable to bind fatty acids; (iii) exclusively polyunsaturated fatty acids were bound by S100A8/A9, whereas saturated (palmitic acid, stearic acid) and monounsaturated fatty acids (oleic acid) as well as arachidonic acid-derived eicosanoids (15-hydroxyeicosatetraenoic acid, prostaglandin E 2 , thromboxane B 2 , leukotriene B 4 ) were poor competitors. Stimulation of neutrophil-like HL-60 cells with phorbol 12-myristate 13-acetate led to the secretion of S100A8/A9 protein complex, which carried the released arachidonic acid. When elevation of intracellular calcium level was induced by A23187, release of arachidonic acid occurred without secretion of S100A8/A9. In view of the unusual abundance in neutrophilic cytosol (approximately 40% of cytosolic protein) our findings assign an important role for S100A8/A9 as mediator between calcium signaling and arachidonic acid effects. Further investigations have to explore the exact function of the S100A8/A9-arachidonic acid complex both inside and outside of neutrophils.The two myeloid-related proteins, MRP8 and MRP14, belong to the S100 family of calcium-binding proteins (for review, see Refs. 1-4). They are composed of two distinct EF-hands flanked by hydrophobic regions at either terminus and separated by a central hinge region, and they form a heterodimeric complex in a Ca 2ϩ -dependent manner. Heizmann and Schä fer (5) proposed a new logical nomenclature for these genes based on the physical arrangement of the genes encoding the S100 family on chromosome 1q21. According to this nomenclature, MRP8 and MRP14 are referred to as S100A8 and S100A9, respectively.Both proteins are expressed in circulating neutrophils and monocytes but are absent in normal tissue macrophages and lymphocytes (6 -9). Under chronic inflammatory conditions, such as psoriasis and malignant disorders, they are also expressed in the epidermis (10 -12). S100A8 and S100A9 are predominantly localized in the cytoplasm. Upon elevation of the intracellular calcium level they are translocated from the cytosol to cytoskeleton and to plasma membrane (13). At a later time point, they appear as noncovalently associated S100A8/A9 heterodimers on the surface of monocytes (14). The mechanism by which the S100A8/A9 heterodimer penetrates the plasma membrane and how the S100A8/A9 protein complex is anchored into the cell membrane, remains unclear since both proteins lack a transmembrane region. Upon th...